Non-Hodgkin Lymphoma

Delaying chemotherapy could be best treatment option

Published in Cancer Weekly, September 2nd, 2003

Delaying chemotherapy until symptoms develop for patients with asymptomatic advanced low-grade non-Hodgkin lymphoma is confirmed as an appropriate strategy, say authors of a U.K. study.

Chemotherapy (single or aggressive combination therapy) does not cure advanced-stage low-grade non-Hodgkin lymphomas, even when combined with radiotherapy. On behalf of the British National Lymphoma Investigation, Kirit Ardeshna from the Mount Vernon Cancer Center, Northwood, U.K., and colleagues compared administration of immediate chemotherapy (chlorambucil) with a policy of delaying chemotherapy until clinical progression necessitated its use, in patients with asymptomatic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-09-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry